BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 10091764)

  • 21. Individual risk evaluation for local recurrence and distant metastasis in Ewing sarcoma: A multistate model: A multistate model for Ewing sarcoma.
    Bosma SE; Rueten-Budde AJ; Lancia C; Ranft A; Dirksen U; Krol AD; Gelderblom H; van de Sande MAJ; Dijkstra PDS; Fiocco M
    Pediatr Blood Cancer; 2019 Nov; 66(11):e27943. PubMed ID: 31389188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ewing's sarcoma: only patients with 100% of necrosis after chemotherapy should be classified as having a good response.
    Albergo JI; Gaston CL; Laitinen M; Darbyshire A; Jeys LM; Sumathi V; Parry M; Peake D; Carter SR; Tillman R; Abudu AT; Grimer RJ
    Bone Joint J; 2016 Aug; 98-B(8):1138-44. PubMed ID: 27482030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
    Brunetto AL; Castillo LA; Petrilli AS; Macedo CD; Boldrini E; Costa C; Almeida MT; Kirst D; Rodriguez-Galindo C; Pereira WV; Watanabe FM; Pizza M; Benites E; Morais V; Gadelha A; Nakasato A; Abujamra AL; Gregianin LJ;
    Pediatr Blood Cancer; 2015 Oct; 62(10):1747-53. PubMed ID: 25917418
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pelvis Ewing sarcoma: Local control and survival in the modern era.
    Ahmed SK; Robinson SI; Arndt CAS; Petersen IA; Haddock MG; Rose PS; Issa Laack NN
    Pediatr Blood Cancer; 2017 Sep; 64(9):. PubMed ID: 28244685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital experience.
    Orr WS; Denbo JW; Billups CA; Wu J; Navid F; Rao BN; Davidoff AM; Krasin MJ
    Ann Surg Oncol; 2012 Nov; 19(12):3816-22. PubMed ID: 22739653
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term Outcomes and Complications in Pediatric Ewing Sarcoma.
    Hamilton SN; Carlson R; Hasan H; Rassekh SR; Goddard K
    Am J Clin Oncol; 2017 Aug; 40(4):423-428. PubMed ID: 25599318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgical treatment for pelvic Ewing sarcoma: What is a safe and functional acetabular reconstruction when combined with modern multidisciplinary treatments?
    Fujiwara T; Lex JR; Stevenson JD; Tsuda Y; Clark R; Parry MC; Grimer RJ; Jeys LM
    J Surg Oncol; 2019 Nov; 120(6):985-993. PubMed ID: 31381161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-Metastatic Pelvic Ewing's Sarcoma : oncologic outcomes and evaluation of prognostic factors.
    Dramis A; Grimer RJ; Malizos K; Tillman RM; Jeys L; Carter LR
    Acta Orthop Belg; 2016 Aug; 82(2):216-221. PubMed ID: 27682283
    [TBL] [Abstract][Full Text] [Related]  

  • 29. What is the impact of local control in Ewing sarcoma: analysis of the first Brazilian collaborative study group - EWING1.
    Becker RG; Gregianin LJ; Galia CR; Jesus-Garcia Filho R; Toller EA; Badell G; Nakagawa SA; David A; Baptista AM; Yonamime ES; Serafini OA; Penna V; Santos JFC; Brunetto AL;
    BMC Cancer; 2017 Jun; 17(1):420. PubMed ID: 28619077
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extraskeletal Ewing sarcomas in late adolescence and adults: a study of 37 patients.
    Tao HT; Hu Y; Wang JL; Cheng Y; Zhang X; Wang H; Zhang SJ
    Asian Pac J Cancer Prev; 2013; 14(5):2967-71. PubMed ID: 23803063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy.
    Delepine N; Delepine G; Cornille H; Voisin MC; Brun B; Desbois JC
    J Chemother; 1997 Oct; 9(5):352-63. PubMed ID: 9373791
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of recurrence and survival after relapse in patients with Ewing sarcoma.
    Stahl M; Ranft A; Paulussen M; Bölling T; Vieth V; Bielack S; Görtitz I; Braun-Munzinger G; Hardes J; Jürgens H; Dirksen U
    Pediatr Blood Cancer; 2011 Oct; 57(4):549-53. PubMed ID: 21442722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pelvic Ewing sarcoma: a retrospective outcome analysis of 104 patients who underwent pelvic tumor resection at a single supra-regional center.
    Guder WK; Hardes J; Nottrott M; Steffen AJ; Dirksen U; Streitbürger A
    J Orthop Surg Res; 2020 Nov; 15(1):534. PubMed ID: 33198775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical impact of post-induction resolution of pulmonary lesions in metastatic Ewing sarcoma.
    Halalsheh H; Kaste SC; Krasin MJ; Sykes A; Sahr N; Spunt SL; Federico SM; Bishop MW
    Pediatr Blood Cancer; 2020 Apr; 67(4):e28150. PubMed ID: 31944574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recurrence of Ewing sarcoma: Is detection by imaging follow-up protocol associated with survival advantage?
    Heinemann M; Ranft A; Langer T; Jürgens H; Kreyer J; Vieth V; Schäfers M; Weckesser M; Simon T; Hassenpflug W; Corbacioglu S; Bielack S; Mayer-Steinacker R; Kühne T; van den Berg H; Gelderblom H; Bauer S; Stegger L; Dirksen U
    Pediatr Blood Cancer; 2018 Jul; 65(7):e27011. PubMed ID: 29480574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cutaneous and subcutaneous Ewing sarcoma.
    Di Giannatale A; Frezza AM; Le Deley MC; Marec-Bérard P; Benson C; Blay JY; Bui B; Judson I; Oberlin O; Whelan J; Gaspar N
    Pediatr Blood Cancer; 2015 Sep; 62(9):1555-61. PubMed ID: 25894676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of radiotherapy in local control of nonextremity Ewing sarcomas.
    Akagunduz OO; Kamer SA; Kececi B; Demirag B; Oniz H; Kantar M; Cetingul N; Sabah D; Anacak Y
    Tumori; 2016; 102(2):162-7. PubMed ID: 26917407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radiation Treatment for Ewing Sarcoma Family of Tumors in Adult Patients: A Single Institution's Experience Over 40 Years.
    Kharod SM; Spiguel AR; Lagmay JP; Jones C; Morris CG; Gibbs CP; Zlotecki RA
    Am J Clin Oncol; 2019 May; 42(5):421-425. PubMed ID: 30883389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow involvement identifies a subgroup of advanced Ewing sarcoma patients with fatal outcome irrespective of therapy in contrast to curable patients with multiple bone metastases but unaffected marrow.
    Thiel U; Wawer A; von Luettichau I; Bender HU; Blaeschke F; Grunewald TG; Steinborn M; Röper B; Bonig H; Klingebiel T; Bader P; Koscielniak E; Paulussen M; Dirksen U; Juergens H; Kolb HJ; Burdach SE
    Oncotarget; 2016 Oct; 7(43):70959-70968. PubMed ID: 27486822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Patients With Localized Ewing Sarcoma at Higher Risk for Local Failure: A Report From the Children's Oncology Group.
    Ahmed SK; Randall RL; DuBois SG; Harmsen WS; Krailo M; Marcus KJ; Janeway KA; Geller DS; Sorger JI; Womer RB; Granowetter L; Grier HE; Gorlick RG; Laack NNI
    Int J Radiat Oncol Biol Phys; 2017 Dec; 99(5):1286-1294. PubMed ID: 28964585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.